• Selective Spectrophotometry of Phenolic β-Lactams

  2026-08-16

  The reference study introduced two rapid spectrophotometric procedures for selectively quantifying four phenolic β-lactam antibiotics in bulk materials and pharmaceutical formulations. By coupling acidic oxidation with cerium(IV) or iron(III) and measuring a common yellow product, the authors developed an accessible alternative for routine quality-control settings, including combinations that challenged existing compendial methods.

• SB-3CT: A Precision Tool for MMP9-Driven ECM Research

  2026-08-15

  SB-3CT is a selective gelatinase inhibitor for dissecting MMP-2 and MMP-9 biology across extracellular-matrix, tumor metastasis, and neural assays. This article connects its mechanism-based pharmacology with new findings on Adamtsl3, perineuronal nets, and cortical plasticity while emphasizing assay interpretation and experimental limits.

• Temafloxacin Workflows for Antibacterial Research

  2026-08-15

  Temafloxacin supports reproducible extracellular susceptibility testing, combination profiling, respiratory infection models, and intracellular work with Mycobacterium avium complex. This guide translates published MIC, FIC, and macrophage-killing methods into practical workflows with concentration planning, controls, and troubleshooting advice.

• Camptothecin in Reliable DNA Damage Assays

  2026-08-14

  Learn how Camptothecin, SKU A2877, can improve the design and interpretation of viability, cytotoxicity, DNA-damage, and autophagy experiments. This scenario-driven guide covers mechanism, solvent compatibility, concentration planning, assay timing, vendor selection, and limits when connecting drug response to adaptive mutagenesis.

• Mupirocin and Novobiocin Activity in Canine Staphylococci

  2026-08-14

  Fulham and colleagues compared in vitro susceptibility to mupirocin and novobiocin among meticillin-susceptible and meticillin-resistant staphylococci from healthy dogs and dogs with superficial pyoderma. The study shows that mupirocin retained substantial activity across isolate groups, whereas novobiocin susceptibility was more variable, particularly among resistant isolates from healthy dogs.

• Position 3-Modified GnRH Antagonists: Activity

  2026-08-13

  The reference study synthesized two degarelix analogs containing racemic 3-(2-methoxy-5-pyridyl)-alanine at position 3 and separated their diastereomers. Its results show that D/L stereochemistry strongly influences human GnRH receptor antagonism, while neither analog retained the parent compound’s long in vivo duration of action.

• Propranolol in Regeneration Research Workflows

  2026-08-13

  Use Propranolol as a controlled β-adrenergic perturbation in avian inner-ear regeneration studies, while separating direct tissue effects from systemic cardiovascular confounding. This workflow combines dose planning, multiplex mRNA imaging, immunohistochemistry, and EdU-based cell-cycle analysis for more interpretable results.

• Streptavidin-HyperFluor 647 Workflow Guide

  2026-08-12

  Streptavidin-HyperFluor 647 combines high-affinity biotin capture with far-red fluorescence for microscopy, flow cytometry, and multiplex assay development. This guide shows how to integrate it into antibody, nucleic-acid, proximity-labeling, and primary-cell workflows while avoiding background, spectral, and labeling-chemistry pitfalls.

• Temafloxacin Workflows for Antibacterial Research

  2026-08-12

  Temafloxacin supports quantitative extracellular susceptibility testing and macrophage-based studies, giving researchers a practical bridge from broad-spectrum screening to intracellular Mycobacterium avium complex models. This workflow emphasizes solvent control, strain-specific combination analysis, and assay choices that distinguish additive activity from true intracellular bactericidal effects.

• FTSJ3 Loss, R-Loop Damage, and Lung Cancer Sensitivity

  2026-08-11

  The 2025 Cancer Letters study identifies FTSJ3 as a regulator of R-loop homeostasis and genomic stability in lung cancer cells. Its loss increases R-loop-associated DNA damage and enhances cisplatin sensitivity, supporting FTSJ3 as a potential biomarker and therapeutic vulnerability while highlighting important translational limitations.

• Verteporfin (CL 318952) for Mechanistic Assays

  2026-08-10

  Verteporfin (CL 318952) enables matched light-on and light-off experiments that separate photodynamic cytotoxicity from p62-linked autophagy inhibition. This guide translates those properties into reproducible apoptosis, vascular, and stem-cell differentiation workflows informed by a recent YAP-TEAD super-enhancer study.

• Methicillin Sodium Salt: From MSSA Models to Translation

  2026-08-09

  Methicillin sodium salt remains a strategically useful tool for connecting penicillin-binding protein biology, MSSA susceptibility testing, and resistance-model design. This thought-leadership article explains how to use its mechanism intelligently, interpret MSSA and MRSA boundaries, and translate lessons from the 2025 EAGLE-1 gonorrhoea trial without confusing a laboratory comparator with a cross-pathogen therapy.

• Methicillin Sodium Salt for MSSA Workflows

  2026-08-08

  Build reproducible MSSA susceptibility assays, gram-positive infection models, and resistance benchmarks with Methicillin sodium salt. This guide combines mechanism-first setup, practical dilution workflows, comparative controls, and troubleshooting while using the EAGLE-2/EAGLE-3 study to sharpen endpoint design.

• Ceruletide (Caerulein) Pancreatic Research Workflows

  2026-08-07

  Build reproducible pancreatic injury, fibrosis, secretion, and motility assays with Ceruletide, also known as Caerulein. This workflow-centered guide connects a defined CCK receptor agonist to antifibrotic testing, including the UCMSC extracellular-vesicle and rhMFGE8 nanoparticle strategy described in recent research.

• EMD638683: A Next-Gen SGK1 Inhibitor for Vascular Research

  2026-08-07

  EMD638683 stands out as a highly selective SGK1 inhibitor, enabling precise dissection of SGK-mediated pathways in vascular stiffening and tumor biology. This article details applied workflows, optimization strategies, and practical troubleshooting for researchers seeking robust, reproducible results in cardiovascular and cancer studies.

455 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page